P46350 Biopharma Development & Production 2018
Download Brochure Request

Register your interest


Register your interest


Biopharma Development & Production 2018

15 – 17 May 2018, Hilton Shanghai Hongqiao Hotel, China

Book Now Download Brochure

EARLY BIRD RATE EXPIRES 16 MARCH 2018 – SAVE UP TO USD200/CNY1000. 早鸟优惠价截止3月16日


With 350+ participants representing the core of China’s market, the Biopharma Development & Production Week is back to spur industry learning, showcase innovation and enable business contacts. With 3 co located conferences, 70+ speakers and over 60 technical and commercial sessions, this is without doubt the only forum with demonstrated value add for participants.

Against the bedrock of emerging and disruptive technologies, new generation facilities and continuous process improvement, participants will get quality practical information that enables them to develop advance capabilities in developing and manufacturing cell lines, biosimilars, biobetters, antibodies, vaccines and novel biologics.

2017 Attendees List

View list >>

Part of

Biopharma Development & Production >>

Co-Located Events

Biosimilars Asia >>
Cell Line Development and Engineering >>
Biomanufacturing >>


Packages Price
2 Day Conference - International Companies, Global HQ Located Outside ChinaUS $1895Early Bird
2 Day Conference - Local China CompaniesUS $977Early Bird
Group of 2 or more delegates - International Companies, Global HQ Located Outside ChinaUS $1495Early Bird
Group of 2 or more delegates - Local China CompaniesUS $752Early Bird
Group of 4 or more delegates - International Companies, Global HQ Located Outside ChinaUS $1295Early Bird
Group of 4 or more delegates - Local China CompaniesUS $676Early Bird
Extras Price
Pre Conference Workshop - International Companies, Global HQ Located Outside China US $300
Pre Conference Workshop - Local China Companies US $150


  • Multiple Bookings Discount pricing is applicable to groups of 2 or more delegates from the same organisation registering for the same event, at the same time.
  • Fee stated is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR group rate.
  • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
  • All delegates from Singapore-based companies are required to pay an additional 7% GST (SINGAPORE EVENTS ONLY)


Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.

View Sponsors and Exhibitors profile >>


Xu Wei

Vice President, Manufacturing, Innovent Biologics, China

Abrar Mir

Managing Partner, Quadria Capital Investment Management Pte Ltd, Singapore

Wang Honglou

CIO, livzon Pharmaceutical Group, China

Jerry Clifford

Chief Operating Officer, Valitacell, Ireland

George Hutchinson

Head of Global Distribution, Solentim

Dr Zhang Peiqing

Analytical Science and Technology Coordinator, Novartis

Sunny Zhou

Professor, Department of Chemistry and Chemical Biology Faculty Fellow, Barnett Institute of Chemical and Biological Analysis Northeastern University, Boston, Massachusetts

Dr. John Yan

Applications Scientist, ProZyme

Hung Fai Poon

Chief Scientific Officer, Zhejiang Hisun Pharmaceutical Co., Ltd, China

Prof. David James

University of Sheffield

Ng Say Kong

Staff Scientist, Animal Cell Technology 2, Bioprocessing Technology Institute, A*STAR

Qingcong Lin

Vice-President, Shenogen Pharma Group, China

Shaoqing Yang

Vice President, Zhejiang Doer Biologics Co.

Jian Dong

VP & Site Head of Manufacturing, Wuxi AppTec, China

Dr. Jinyou Zhang

Senior Vice President/Head, Bio Development and Manufacturing, BeiGene Co. Ltd., China

Barbara A. Paldus, Ph.D.

Vice President & General Manager, Finesse, part of Thermo Fisher Scientific, U.S.

David Sadler

President & CEO, Kunshan Zotek Kinglai Co. Ltd. U.K.

Wendy Chiang

Managing Director of Microbial Solutions, Greater China Region, Charles River Laboratories

Dr Yvan Ruland

Technology Manager Biopharma, Novasep, China

Bo Qi

M.Sc. Vice President Head of CMC General Manager, Generon Beijing, China

Joycelyn Kwek

Former Director, Quality Assurance, Amgen Singapore

Hui Cai

Head of QC Laboratory 2 & Head of Microbial Control Team, WuXi Biologics, China

Dr. Dennis Yu Xia

Vice President of Manufacturing and Quality, Akeso Bio, China

Dr. John Zeng

Executive Vice President, Bioprocess Development & Pilot Plant Manufacturing, Shanghai Zerun Biotech Co Ltd, China

Grace Zheng

Head of Bioprocess, ZaiLab, Ltd.

Noel Rob

Business Development Manager, Pall Life Sciences, UK

Dr. Christopher J. Hickey

Senior Director Government Affairs, Market Access & Communications, Pfizer

Dr. Scott Liu

President and CEO, Shanghai Henlius Biotech Inc.

Dr. Lutz Hilbrich

Head Strategic Task Force Biologics, Sanofi

Jiang Junjun

Assistant Director, WuXi Biologics

Wen Yong

Vice Director, Drug Research Institutes, Biopharmaceutical Institute, Jiangsu Aosaikang Pharmaceutical Co Ltd, China

Dr. Jacqueline Ming Liu

Vice President, TOT Biopharma, China

Dr Qiwei Wu

Ph.D, Vice President of Process Development and Manufacturing, Livzon Mabpharma

Dr Amy Hong Que

Vice President - Quality, Innovent Biologics

Ai-Min Hui

Chief Medical Officer, Shanghai Fosun Pharma

Prof. Dr. Florian Turk

Head Global Payor Marketing, Sales and Relations, Sandoz Biopharmaceuticals Sandoz International GmbH, Germany

Pearl Fong

Associate Vice President, Division of Project Development, Mycenax Biotech Inc., Taiwan

Bryan Kim

Vice President of Business Development, Samsung Bioepis, Korea

Dr. Xin Zhang

Head of Global Clinical Operations and Affairs, Shanghai Henlius Biotech Co Ltd, China

Sunit Maity

Director, Product Development, Zumutor Biologics, India

MinSeob Lee

Team Leader of R&D CMC/PM, Celltrion R&D, Korea

Mitul Agarwal

General Manager - Business Development & Licensing, Intas Pharmaceuticals, India

Alvin Luk

Senior Vice President and Chief Medical Officer - Global Clinical Operations and Affairs, Shanghai Henlius Biotech Co Ltd, China

Dr Jun Yuan

Vice President, Quacell Biotech, China

Jerry Yang

SVP, Process & Product Development, Hangzhou JUST Biotherapeutics Co., Ltd., China

Dong Huifang

Director of Cell Line Development, WuXi Biologics, China

Eric Chang

Head of Cell Line Development, JHL Biotech, Taiwan

Sam Zhang

Senior Principal Scientist/Group Leader, Cell Line Development, Bioprocess R&D, Pfizer Inc, USA

Debby Chang

Associate Director – Cell Line Engineering and Development, Shanghai Hengrui Pharmaceutical, China

Sai Ling Liu

Chief Scientific Officer, Surfer Biotech, China

Wen Zaiqing

Vice President of CMC, Generon Corpoation (Shanghai) Limited, China

Dr. Li Shi

Chief Executive Officer, Shanghai Zerun Biotech Co. Ltd

Eric Liu

China Biosimilars Regulation Publishing Manager, Pfizer

Zheru Zhang

President, I-Mab Biopharma, China

Zack Zheng

Ph.D. VP of Process Development (Wuhan), JHL BioTech, China

Masayoshi Nagaya

Sr. Global Technology Manager, JSR Life Sciences

Dr. Frank Ye

SVP of Manufacturing and Quality, Hangzhou Just Biotherapeutics Co., Ltd., China

John Dubczak

Director of Operations, Charles River Laboratories, U.S.

Dr. Bin Wang

Head of Business Development, Boehringer Ingelheim Biopharmaceuticals, China

Yifang Wu

President, Wanbang Biopharmaceuticals Co., Ltd, China

when & where

15 - 17 May 2018

Hilton Shanghai Hongqiao
No. 1116 Hong Song East Rd, Shanghai, 201103, China
Tel: +86-21-3323 6666


Still have a question?

Speaking Opportunities
Win Min
+65-6508 2873

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489


Media & Association Partnership Opportunities
June Tan
+65 6508 2465


IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more